What The Study Did: The purpose of this randomized clinical trial in France was to evaluate the effect of low-dose hydrocortisone for the treatment of ICU patients with COVID-19-related acute respiratory failure but the trial was stopped early.
Authors: Pierre-François Dequin, M.D., Ph.D., of Médecine Intensive-Réanimation in Tours, France, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2020.16761)
Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
###
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.16761?guestAccessKey=87249cc0-d27a-4fd1-92de-82c71732a4c2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090220
JAMA